MA52869A - Peptides ayant une activité inhibitrice sur l'exocytose neuronale - Google Patents

Peptides ayant une activité inhibitrice sur l'exocytose neuronale

Info

Publication number
MA52869A
MA52869A MA052869A MA52869A MA52869A MA 52869 A MA52869 A MA 52869A MA 052869 A MA052869 A MA 052869A MA 52869 A MA52869 A MA 52869A MA 52869 A MA52869 A MA 52869A
Authority
MA
Morocco
Prior art keywords
inhibitoring
peptides
activity
neuronal exocytosis
exocytosis
Prior art date
Application number
MA052869A
Other languages
English (en)
Inventor
Cristina Bartella
Giner Isabel Devesa
Ballester Gregorio Fernandez
Montiel Antonio Ferrer
Francesca Mancini
Giorgina Mangano
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MA52869A publication Critical patent/MA52869A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
MA052869A 2018-06-13 2019-06-11 Peptides ayant une activité inhibitrice sur l'exocytose neuronale MA52869A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18177586 2018-06-13

Publications (1)

Publication Number Publication Date
MA52869A true MA52869A (fr) 2021-04-21

Family

ID=62636027

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052869A MA52869A (fr) 2018-06-13 2019-06-11 Peptides ayant une activité inhibitrice sur l'exocytose neuronale

Country Status (7)

Country Link
US (1) US12377035B2 (fr)
EP (1) EP3807293B1 (fr)
JP (2) JP7488198B2 (fr)
EA (1) EA202190017A1 (fr)
ES (1) ES3060502T3 (fr)
MA (1) MA52869A (fr)
WO (1) WO2019238683A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022162312A1 (fr) * 2021-01-27 2022-08-04 Fabien Schweighoffer Peptides et leurs utilisations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2334897A (en) 1996-03-18 1997-10-10 Regents Of The University Of California, The Peptide inhibitors of neurotransmitter secretion by neuronal cells
ES2160485B1 (es) 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
US6866856B2 (en) 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
SG160358A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of an oligopeptide
US7566464B2 (en) 2005-09-01 2009-07-28 Belfer William A Cosmetic composition to accelerate repair of functional wrinkles
ES2322882B1 (es) 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.
ES2356883B1 (es) 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
US20100281003A1 (en) * 2009-04-02 2010-11-04 New York University System and uses for generating databases of protein secondary structures involved in inter-chain protein interactions
WO2011048443A1 (fr) 2009-10-20 2011-04-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Peptides inhibant l'exocytose neuronale dérivés de la sous-unité c de v-atpase et compositions cosmétiques et pharmaceutiques contenant lesdits peptides
WO2011119484A1 (fr) * 2010-03-23 2011-09-29 Iogenetics, Llc Procédés bioinformatiques pour déterminer la liaison de peptides
WO2013040142A2 (fr) * 2011-09-16 2013-03-21 Iogenetics, Llc Procédés bio-informatiques de détermination de liaisons peptidiques
EP2802337B2 (fr) 2011-11-07 2021-01-20 Feng Tian Composés à base de peptide en tant qu'inhibiteurs de la sécrétion d'un neurotransmetteur
EP2649985A1 (fr) 2012-04-13 2013-10-16 Lipotec, S.A. Composés inhibant l'exocytosis neuronale (III)
EP4001920A1 (fr) * 2014-04-03 2022-05-25 AllerGenis, LLC Peptides et méthodes permettant de détecter une allergie alimentaire
DK3397970T3 (da) * 2015-12-29 2023-08-21 Sanofi Sa Fremgangsmåder til karakterisering af sammensætninger, der omfatter jordnøddeantigener
US20170349638A1 (en) 2016-03-21 2017-12-07 Aileron Therapeutics, Inc. Companion diagnostic tool for peptidomimetic macrocycles

Also Published As

Publication number Publication date
EP3807293C0 (fr) 2026-01-14
US12377035B2 (en) 2025-08-05
EA202190017A1 (ru) 2021-03-17
JP7488198B2 (ja) 2024-05-21
JP2024054255A (ja) 2024-04-16
EP3807293A1 (fr) 2021-04-21
EP3807293B1 (fr) 2026-01-14
ES3060502T3 (en) 2026-03-26
JP2021527085A (ja) 2021-10-11
WO2019238683A1 (fr) 2019-12-19
US20220296489A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
EP4426043C0 (fr) Configuration de zones multiples
EP3655836A4 (fr) Repositionnement d'un véhicule autonome
EP3898997A4 (fr) Vecteurs d'orthopoxvirus modifiés
EP3894015B1 (fr) Composition de shampooing comprenant des microcapsules stratiformes
EP3433382A4 (fr) Spike-ins d'acides nucléiques synthétiques
EP3430731A4 (fr) Architecture d'iugw
EP3855907A4 (fr) Bain pour animal de compagnie
EP3735467A4 (fr) Vecteurs de la vaccine modifiés
EP3968764A4 (fr) Peigne pour animal domestique
EP3518708A4 (fr) Structure d'assise souple
EP3589640A4 (fr) Purification de protéines avec la protéine l
MA45684A (fr) Protéine d'apport du cerveau
EP3788142A4 (fr) Virus contre la vaccine chimérique synthétique
EP3735466A4 (fr) Vecteurs d'orthopoxvirus modifiés
EP3571751A4 (fr) Architecture d'optimiseurs central/ distribués
DK3737402T5 (da) Modificeret protein
EP3805381A4 (fr) Phytase mutée
MA53493A (fr) Polypeptides leurres
EP3755296A4 (fr) Support d'assise
DK3433359T3 (da) Forbedret rengøringsydelse på proteinfølsomme tilsmudsninger
EP3826440A4 (fr) Barrette intelligente
EP3401771A4 (fr) Interface d'interaction intelligente
EP3833084A4 (fr) Configuration d'instance openflow
EP3761922C0 (fr) Support d'épaule orthétique
EP3755376A4 (fr) Formulations contenant des protéases affectant la mucine